Takeda Pharmaceutical Company Limited
TKPHF
$30.58
$0.391.29%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -442.98% | 940.31% | -109.30% | 227.09% | -533.93% |
| Total Depreciation and Amortization | 342.38% | -206.70% | -0.26% | -65.84% | 349.82% |
| Total Amortization of Deferred Charges | -186.13% | -- | -- | -- | -190.25% |
| Total Other Non-Cash Items | -77.06% | -38.18% | 415.98% | -145.14% | 57.58% |
| Change in Net Operating Assets | 715.64% | -271.56% | 163.75% | -1,337.72% | -96.76% |
| Cash from Operations | -80.74% | -5.57% | 71.95% | 2.32% | -42.07% |
| Capital Expenditure | -7.43% | 0.64% | 18.04% | -3.61% | -8.29% |
| Sale of Property, Plant, and Equipment | 247.38% | -- | -100.00% | 20,951.43% | 300.00% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -84.30% | 755.56% | -98.82% | 181.84% | 770.93% |
| Other Investing Activities | 93.84% | -2,081.83% | 60.78% | -222.07% | 125.27% |
| Cash from Investing | 75.64% | -356.85% | -42.02% | -77.96% | 82.96% |
| Total Debt Issued | -- | -100.00% | 86.60% | 567.72% | -31.28% |
| Total Debt Repaid | -766.02% | 96.77% | -66.70% | 20.55% | 54.79% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | 100.00% | -3.25% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 94.31% | -1,522.96% | 94.08% | -1,474.33% | 93.30% |
| Other Financing Activities | -28.52% | 15.65% | -120.53% | 53.27% | 2.69% |
| Cash from Financing | 61.15% | -1,437.05% | 94.54% | 24.86% | 53.96% |
| Foreign Exchange rate Adjustments | -95.28% | 60.71% | 637.51% | 73.51% | -142.43% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -117.59% | -107.66% | 1,024.77% | 66.02% | 70.10% |